ArticleDiscover oncology2026
Chronic multifocal collagenous fibroma with tumor development at surgical incision site: a 46-year case report.
Article in Discover oncology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
backgroundCollagenous fibroma (CF), also known as desmoplastic fibroblastoma, is a rare benign fibroblastic/myofibroblastic tumor characterized by FOSL1/FOS rearrangements. CF typically presents as a solitary, slow-growing mass in middle-aged adults. This case presents three extraordinarily rare features: pediatric onset at age 5, chronic multifocal disease over 46 years, and rapid post-surgical growth at a sternotomy site. Surgical excision is the preferred treatment. CASE PRESENTATION: We report a 51-year-old male with chronic, multifocal CF beginning at age 5 and persisting over 46 years, predominantly affecting the right side. In 2022, a rapidly enlarging mass (25 × 7 cm) developed at a pericardial window incision site within 2-3 years post-procedure. Core needle biopsy at an outside institution showed overlapping features with desmoid fibromatosis. Following an unsuccessful trial of imatinib, comprehensive immunohistochemical analysis at our institution definitively established the diagnosis of CF. Marginal excision with local flap reconstruction resulted in R1 margins. MRI demonstrated T1 isointensity and low T2 signal. Histopathology revealed sparsely cellular spindle-cell proliferation in dense collagenous stroma. Immunohistochemistry showed cytoplasmic/membranous β-catenin expression without nuclear accumulation, low Ki-67 index, and nuclear FOSL1 positivity. The postoperative course was uneventful, with no new lesions at 5-month follow-up.
conclusionThis case presents an extraordinary constellation of three rare features: (1) pediatric onset at age 5; (2) chronic multifocal disease persisting over 46 years; and (3) rapid post-surgical growth suggesting trauma-associated tumorigenesis. These features justify comprehensive molecular analysis and long-term surveillance.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.